Related Experiment Videos
Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity
1Institute for Advanced Study, Princeton, NJ 08540, USA. wodarz@ias.edu
Insights
Exposure to multiple viral infections weakens cytotoxic T-lymphocyte (CTL) memory, hindering the immune system's ability to control viral replication and potentially accelerating immune aging. This impacts vaccination and treatment strategies.
Area of Science:
- Immunology
- Mathematical Biology
- Virology
Background:
- Cytotoxic T-lymphocyte (CTL) memory is crucial for viral clearance.
- Traditionally studied in isolation, CTL memory is now understood to be affected by heterologous (antigenically different) viral challenges.
- Previous research suggests that encountering multiple infections can lead to the attrition of existing CTL memory.
Purpose of the Study:
- To explore the impact of multiple, antigenically distinct viral infections on CTL memory dynamics using mathematical models.
- To understand how these dynamics affect the immune system's capacity to control concurrent and subsequent viral infections.
- To investigate the consequences for viral clearance and overall immune control.
Main Methods:
- Development and analysis of mathematical models simulating CTL memory responses to single and multiple viral infections.
- Modeling antigen-independent persistence of CTL memory.
- Simulating the effects of increasing numbers of heterologous antigenic stimuli on viral load and CTL populations.
Main Results:
- Antigen-independent persistence of CTL memory is essential for effective viral clearance.
- Exposure to a threshold number of heterologous viral challenges significantly reduces immunological pressure at low viral loads.
- This reduction in pressure impairs virus clearance, diminishes overall viral replication control, and can lead to a net decrease in memory CTLs beyond a certain infection threshold.
Conclusions:
- Multiple heterologous viral infections compromise the effectiveness of CTL memory in controlling viral load.
- The findings suggest a potential mechanism for age-related decline in immunity, where repeated pathogen exposure accelerates immune system aging.
- These insights have significant implications for designing effective vaccination and antiviral treatment strategies, particularly in the context of complex or persistent infections.
Abstract:
Cytotoxic T-lymphocyte (CTL) memory to viruses has traditionally been studied in an isolated setting. However, recent experiments have indicated that the presence of antigenically heterologous challenges can result in the attrition of CTL memory. Here we use mathematical models in order to explore the consequence of these dynamics for the ability of the immune system in controlling multiple infections. Mathematical models suggest that antigen-independent persistence of CTL memory is required in order to resolve and clear an infection. This ensures strong immunological pressure at low loads when the virus population declines towards extinction. If the number of antigenic stimuli exposed to the immune system crosses a threshold, we find that immunological pressure is significantly reduced at low loads and this can prevent virus clearance and reduces overall control of viral replication. Hence, exposure to many heterologous challenges reduces the ability of CTL memory to contribute to virus control. The higher the number of infections present in the host, the higher the overall virus load and the higher the total number of memory CTLs. Beyond a given threshold, addition of new viruses to the system results in accelerated loss of virus control which eventually leads to a reduction in the overall memory CTL population. These dynamics might contribute to the progressively weaker immunity observed as a result of ageing. In this context, antigenically variable pathogens expose the immune system to many heterologous challenges within a short period of time and this could result in accelerated ageing of the immune system. These results have important implications for vaccination and treatment strategies directed against viral infections.